BackTheseus Pharmaceuticals Overview

Theseus Pharmaceuticals Operating Income

Operating Income for THRX.

Quarterly Operating Income

$-16403000.00
2.85% YoY

As of Sep 30, 2023

Annual Operating Income (TTM)

$-66524000.00
40.74% YoY

Trailing 12 months ending Sep 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)